These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 17052691

  • 21. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
    Yagi M, Ninomiya K, Fujita N, Suzuki T, Iwasaki R, Morita K, Hosogane N, Matsuo K, Toyama Y, Suda T, Miyamoto T.
    J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
    [Abstract] [Full Text] [Related]

  • 22. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
    Huang H, Ryu J, Ha J, Chang EJ, Kim HJ, Kim HM, Kitamura T, Lee ZH, Kim HH.
    Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
    [Abstract] [Full Text] [Related]

  • 23. RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways.
    Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K.
    Biochem Biophys Res Commun; 2007 Jun 15; 357(4):945-50. PubMed ID: 17467668
    [Abstract] [Full Text] [Related]

  • 24. Irreversible inhibition of RANK expression as a possible mechanism for IL-3 inhibition of RANKL-induced osteoclastogenesis.
    Khapli SM, Tomar GB, Barhanpurkar AP, Gupta N, Yogesha SD, Pote ST, Wani MR.
    Biochem Biophys Res Commun; 2010 Sep 03; 399(4):688-93. PubMed ID: 20691668
    [Abstract] [Full Text] [Related]

  • 25. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
    Lee MS, Kim HS, Yeon JT, Choi SW, Chun CH, Kwak HB, Oh J.
    J Immunol; 2009 Sep 01; 183(5):3390-9. PubMed ID: 19641137
    [Abstract] [Full Text] [Related]

  • 26. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR.
    Gene; 2009 Oct 15; 446(2):90-8. PubMed ID: 19563866
    [Abstract] [Full Text] [Related]

  • 27. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY, Yoon KH, Choi MK, Lee MS, Oh J.
    Bone; 2015 Oct 15; 79():242-51. PubMed ID: 26103094
    [Abstract] [Full Text] [Related]

  • 28. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA.
    Bone; 2006 May 15; 38(5):678-85. PubMed ID: 16309985
    [Abstract] [Full Text] [Related]

  • 29. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
    Kim WS, Kim HJ, Lee ZH, Lee Y, Kim HH.
    Exp Cell Res; 2013 Feb 15; 319(4):436-46. PubMed ID: 23246654
    [Abstract] [Full Text] [Related]

  • 30. RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation.
    Kim JH, Kim K, Youn BU, Jin HM, Kim JY, Moon JB, Ko A, Seo SB, Lee KY, Kim N.
    Biochem J; 2011 Jun 01; 436(2):253-62. PubMed ID: 21413932
    [Abstract] [Full Text] [Related]

  • 31. Beta-glycerophosphate accelerates RANKL-induced osteoclast formation in the presence of ascorbic acid.
    Noh AL, Yim M.
    Pharmazie; 2011 Mar 01; 66(3):195-200. PubMed ID: 21553650
    [Abstract] [Full Text] [Related]

  • 32. Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation.
    Park EK, Kim MS, Lee SH, Kim KH, Park JY, Kim TH, Lee IS, Woo JT, Jung JC, Shin HI, Choi JY, Kim SY.
    Biochem Biophys Res Commun; 2004 Dec 24; 325(4):1472-80. PubMed ID: 15555594
    [Abstract] [Full Text] [Related]

  • 33. Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1beta-stimulated osteoclast differentiation through downregulation of MAPKs, c-Fos and NFATc1.
    Lee EG, Yun HJ, Lee SI, Yoo WH.
    Korean J Intern Med; 2010 Mar 24; 25(1):93-100. PubMed ID: 20195410
    [Abstract] [Full Text] [Related]

  • 34. Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation.
    Regmi A, Fuson T, Yang X, Kays J, Moxham C, Zartler E, Chandrashekhar S, Galvin RJ.
    Bone; 2005 Feb 24; 36(2):284-91. PubMed ID: 15780954
    [Abstract] [Full Text] [Related]

  • 35. The molecular understanding of osteoclast differentiation.
    Asagiri M, Takayanagi H.
    Bone; 2007 Feb 24; 40(2):251-64. PubMed ID: 17098490
    [Abstract] [Full Text] [Related]

  • 36. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T, Hasegawa S, Asai M, Ninomiya T, Sasaki T, Cha BY, Teruya T, Ozawa H, Yagasaki K, Nagai K, Woo JT.
    Eur J Pharmacol; 2011 Jan 15; 650(2-3):511-8. PubMed ID: 21047508
    [Abstract] [Full Text] [Related]

  • 37. Pim-1 regulates RANKL-induced osteoclastogenesis via NF-κB activation and NFATc1 induction.
    Kim K, Kim JH, Youn BU, Jin HM, Kim N.
    J Immunol; 2010 Dec 15; 185(12):7460-6. PubMed ID: 21068407
    [Abstract] [Full Text] [Related]

  • 38. A novel PPARgamma agonist, KR62776, suppresses RANKL-induced osteoclast differentiation and activity by inhibiting MAP kinase pathways.
    Park JY, Bae MA, Cheon HG, Kim SS, Hong JM, Kim TH, Choi JY, Kim SH, Lim J, Choi CH, Shin HI, Kim SY, Park EK.
    Biochem Biophys Res Commun; 2009 Jan 16; 378(3):645-9. PubMed ID: 19059209
    [Abstract] [Full Text] [Related]

  • 39. Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1.
    Kwak HB, Yang D, Ha H, Lee JH, Kim HN, Woo ER, Lee S, Kim HH, Lee ZH.
    Exp Mol Med; 2006 Jun 30; 38(3):256-64. PubMed ID: 16819284
    [Abstract] [Full Text] [Related]

  • 40. Esculetin attenuates receptor activator of nuclear factor kappa-B ligand-mediated osteoclast differentiation through c-Fos/nuclear factor of activated T-cells c1 signaling pathway.
    Baek JM, Park SH, Cheon YH, Ahn SJ, Lee MS, Oh J, Kim JY.
    Biochem Biophys Res Commun; 2015 May 29; 461(2):334-41. PubMed ID: 25887803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.